Misty Copeland changed what was possible for generations of dancers to come. Jim and Kate sit down with Misty to talk about the determination it took to reach the top and why her focus today is on creating opportunity for others. They discuss motherhood and the work she's doing through The Misty Copeland Foundation to help young artists see themselves in spaces where they belong. This is a conversation about building something bigger than yourself.

Misty Copeland changed what was possible for generations of dancers to come. Jim and Kate sit down with Misty to talk about the determination it took to reach the top and why her focus today is on creating opportunity for others. They discuss motherhood and the work she's doing through The Misty Copeland Foundation to help young artists see themselves in spaces where they belong. This is a conversation about building something bigger than yourself.

As the founder of internationally acclaimed global health innovation company Real Chemistry, Jim Weiss knows that the key to success and leveraging one's mission is connection -- so he's reached out to innovators in and outside of healthcare to discuss what's now and what's next. He's interviewing world-renowned scientists, CEOs, public health experts, and the list goes on! It's time to GET REAL about the future of healthcare and how to be better health citizens.

Get Real with Jim Weiss

Misty Copeland: Prima Ballerina and Founder of The Misty Copeland Foundation

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/948ced19-ab4e-4d77-9f92-b47301298c4a/transcript

Renée Fleming has spent her life mastering sound. Now, she’s convincing science to see its power. Renée joins Jim to explore Music and Mind, her groundbreaking book, and Music as Medicine, their pioneering initiative with the Foundation for the National Institutes of Health (FNIH), focused on advancing research at the intersection of music, neuroscience, and healthcare. You'll learn about their partnership bringing scientists, clinicians, and artists together. You'll also hear why music affects everything from cognition to neurodegenerative disease, and how this growing body of research will transform healthcare. It’s a conversation about what is possible when science takes seriously something humans have always known: music changes us.

Ren&eacute;e Fleming has spent her life mastering sound. Now, she&rsquo;s convincing science to see its power. Ren&eacute;e joins Jim to explore Music and Mind, her groundbreaking book, and Music as Medicine, their pioneering initiative with the Foundation for the National Institutes of Health (FNIH), focused on advancing research at the intersection of music, neuroscience, and healthcare. You'll learn about their partnership bringing scientists, clinicians, and artists together. You'll also hear why music affects everything from cognition to neurodegenerative disease, and how this growing body of research will transform healthcare. It&rsquo;s a conversation about what is possible when science takes seriously something humans have always known: music changes us.

Renée Fleming: Opera Singer, Advocate for Music as Medicine with The FNIH

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/20bc8d83-4a59-4618-aa7a-b478011f827e/transcript

For Maimah Karmo, surviving cancer was just the beginning. In this episode of Get Real, Jim sits down with Maimah, founder and CEO of the Tigerlily Foundation, who is 20 years out from a diagnosis of stage two triple negative breast cancer. Maimah made a decision early on: she wasn’t just going to survive, she was going to live with intention. She shares how her upbringing, from Liberia to building a life in the U.S., shaped her instinct to advocate for herself and others. And how, after her first chemotherapy treatment, she began building Tigerlily with nothing but a question, a prayer, and a purpose. They get real about what it means to thrive after cancer — physically, mentally, and emotionally. From daily practices  to discipline to building community. Maimah shows that longevity isn’t just about time.It’s about how you choose to live it.

For Maimah Karmo, surviving cancer was just the beginning. In this episode of Get Real, Jim sits down with Maimah, founder and CEO of the Tigerlily Foundation, who is 20 years out from a diagnosis of stage two triple negative breast cancer. Maimah made a decision early on: she wasn’t just going to survive, she was going to live with intention. She shares how her upbringing, from Liberia to building a life in the U.S., shaped her instinct to advocate for herself and others. And how, after her first chemotherapy treatment, she began building Tigerlily with nothing but a question, a prayer, and a purpose. They get real about what it means to thrive after cancer — physically, mentally, and emotionally. From daily practices to discipline to building community. Maimah shows that longevity isn’t just about time.It’s about how you choose to live it.

Maimah Karmo Is Redefining What It Means To Survive

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2606e399-69b5-474b-9466-b4720138753a/transcript

For decades, the biotech industry has been concentrated in a handful of coastal hubs. But according to Isaac Barchas, one of the most significant opportunities in medicine may be hiding in plain sight.In this episode of Get Real, Jim Weiss sits down with Isaac Barchas, co-founder of Arsenal Bridge Ventures, to discuss why world-class scientific research is happening far beyond Boston and Silicon Valley, and why investors have been overlooking it for years.Isaac shares Arsenal Bridge's mission to identify breakthrough discoveries emerging from universities and research institutions across America's heartland, provide the capital and leadership needed to commercialize them, and help transform promising science into life-changing therapies.Together, Jim and Isaac explore the future of biotech innovation, the challenges of building companies outside traditional venture capital hubs, and why investing in overlooked regions could be good for patients, good for business, and good for America.

For decades, the biotech industry has been concentrated in a handful of coastal hubs. But according to Isaac Barchas, one of the most significant opportunities in medicine may be hiding in plain sight.In this episode of Get Real, Jim Weiss sits down with Isaac Barchas, co-founder of Arsenal Bridge Ventures, to discuss why world-class scientific research is happening far beyond Boston and Silicon Valley, and why investors have been overlooking it for years.Isaac shares Arsenal Bridge's mission to identify breakthrough discoveries emerging from universities and research institutions across America's heartland, provide the capital and leadership needed to commercialize them, and help transform promising science into life-changing therapies.Together, Jim and Isaac explore the future of biotech innovation, the challenges of building companies outside traditional venture capital hubs, and why investing in overlooked regions could be good for patients, good for business, and good for America.

Isaac Barchas Sees The Next Biotech Boom

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/134e5e76-ae30-4c67-9fb2-b47201386c36/transcript

Misty Copeland: Prima Ballerina and Founder of The Misty Copeland Foundation

Get Real with Jim Weiss

In 1 playlist(s)

Get Real with Jim Weiss

Social links

Follow podcast

Recent clips